UroToday
Education · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11448 Deerfield Dr Ste 2, Truckee, Calif...Phone Number
(510) 540-0930Website
www.urotoday.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About UroToday
UroToday is a leading platform dedicated to providing education in urology and genitourinary oncology, focusing on multidisciplinary care teams. The company offers a wide range of resources including clinical trials, genomic biomarker testing, and treatment options for various urologic cancers such as prostate, bladder, and kidney cancer. Their intended clients include healthcare professionals, researchers, and patients seeking the latest information and advancements in urologic oncology. UroToday aims to enhance patient care through innovative educational initiatives and collaborative research efforts.Explore more
UroToday Org Chart
TB
Office Manager
NS
Manager, Content
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is UroToday your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if UroToday had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if UroToday has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when UroToday launches new products
Congratulate Masked Content for being promoted to Masked Content at UroToday
Earning: See what the market has to say on UroToday recently announced quarterly report
Check out if UroToday is spiking on competitors!
UroToday, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once UroToday has new funding data
Recommended Actions
Find VP level buyers at UroToday
Find 3 more new buyers
Compare Similar Companies to UroToday
Compare insights from companies similar to UroToday, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
UroToday is experiencing very low activity levels compared to other companies in the Education sector.
What does this means?
UroToday is drawing exceptional interest within the Education industry, suggesting notable developments or strong market momentum, learn more about UroToday.
UroToday Tech Stack
A closer look at the technologies used by UroToday
UroToday News & Media
Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX) today announced the publication of three podcasts with UroToday highlighting the company’s recent FDA approval of ANKTIVA® (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) for non-muscle invasive bladder cancer (NMIBC) carcinoma in situ (CIS) and advances in bladder cancer research. Patrick Soon-Shiong, M.D., Executive Chairman and Global Chief Scientific at ImmunityBio, discussed the breakinUroToday and PRIMR Announce Strategic Partnership to Enhance Clinical Trial Awareness
Digital Science Press / UroToday RENO, Nev., March 5, 2024 /PRNewswire/ -- UroToday, the premier global hub for urology news and education, and PRIMR, a pioneering oncology clinical trial patient education company, proudly announce their inaugural strategic partnership. This...International Bladder Cancer Group (IBCG) and UroToday Announce Formal Partnership to Enhance Patient Outreach
Digital Science Press / UroToday RENO, Nev., Nov. 27, 2023 /PRNewswire/ -- The International Bladder Cancer Group (IBCG) and UroToday, a leading global resource for urology news and education, are proud to announce our formal partnership to collaborate on improving patient outreach and...THE PROSTATE CANCER FOUNDATION ANNOUNCES THE ACQUISITION OF UROTODAY.COM AND DIGITAL SCIENCE PRESS
LOS ANGELES, Jan. 5, 2022 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced it has acquired Digital Science Press, Inc., (DSP) digital publisher of UroToday.com and a global leader in providing evidence-based clinical content and educational resources within the fields...
Read more news
Top Education Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding UroToday
Sign Up For FreeTo access detailed company insights
UroToday is a leading platform dedicated to providing education in urology and genitourinary oncology, focusing on multidisciplinary care teams. The company offers a wide range of resources including clinical trials, genomic biomarker testing, and treatment options for various urologic cancers such as prostate, bladder, and kidney cancer. Their int... Read More
